- Home
- PSIX vs REPL Comparison
PSIX vs REPL Comparison
Compare PSIX & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSIX
- REPL
- Stock Information
- Founded
- PSIX 1985
- REPL 2015
- Country
- PSIX United States
- REPL United States
- Employees
- PSIX N/A
- REPL N/A
- Industry
- PSIX Industrial Machinery/Components
- REPL Biotechnology: Pharmaceutical Preparations
- Sector
- PSIX Industrials
- REPL Health Care
- Exchange
- PSIX Nasdaq
- REPL Nasdaq
- Market Cap
- PSIX 845.8M
- REPL 780.3M
- IPO Year
- PSIX N/A
- REPL 2018
- Fundamental
- Price
- PSIX $35.05
- REPL $10.14
- Analyst Decision
- PSIX Strong Buy
- REPL Strong Buy
- Analyst Count
- PSIX 1
- REPL 6
- Target Price
- PSIX $37.00
- REPL $17.50
- AVG Volume (30 Days)
- PSIX 306.6K
- REPL 794.9K
- Earning Date
- PSIX 01-01-0001
- REPL 02-06-2025
- Dividend Yield
- PSIX N/A
- REPL N/A
- EPS Growth
- PSIX 100.56
- REPL N/A
- EPS
- PSIX 2.37
- REPL N/A
- Revenue
- PSIX $436,423,000.00
- REPL N/A
- Revenue This Year
- PSIX $4.98
- REPL N/A
- Revenue Next Year
- PSIX $7.89
- REPL $300.41
- P/E Ratio
- PSIX $14.81
- REPL N/A
- Revenue Growth
- PSIX N/A
- REPL N/A
- 52 Week Low
- PSIX $1.70
- REPL $4.92
- 52 Week High
- PSIX $38.87
- REPL $17.00
- Technical
- Relative Strength Index (RSI)
- PSIX N/A
- REPL 32.06
- Support Level
- PSIX N/A
- REPL $10.00
- Resistance Level
- PSIX N/A
- REPL $11.20
- Average True Range (ATR)
- PSIX 0.00
- REPL 0.84
- MACD
- PSIX 0.00
- REPL -0.20
- Stochastic Oscillator
- PSIX 0.00
- REPL 3.93
About PSIX Power Solutions International Inc. Common Stock
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction, and irrigation. The company generates majority of its sales from United States.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.